Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer.
Totonji S, Ramos-Triguero A, Willmann D, Sum M, Urban S, Bauer H, Rieder A, Wang S, Greschik H, Metzger E, Schüle R.
Totonji S, et al. Among authors: rieder a.
Cancers (Basel). 2024 Apr 17;16(8):1532. doi: 10.3390/cancers16081532.
Cancers (Basel). 2024.
PMID: 38672614
Free PMC article.